with values of 600 billion by analyst, its a hugely undervalued unit!
short here are like shooting into a barrel of carp! They won't know what hit them!
hedge funds see this as an easy squeeze of a float that is totally short and too much good news coming out this month
DNDN wasn't a drug but a process of extracting something from your body, enhancing it to fight off cancer............like comparing a grapefruit to a piece of candy!
This is a drug that works and has a big market out there
once you hear of first rumor of buyout it usually takes 6 months of back and forth negotiations until a final agreement is struck and announced. In the case of RLYP, i'm betting there is multiple buyers in the process which takes time to weed out the ones not willing to go over a set price. The prescription numbers will get buyers excited if they continue to come in strong.
thats a set up for a major squeeze! lol
looks like its already starting
50 day moving average is 195, when it breaks it will be a stampede by shorts to cover
she was just making political hay on subject after VRX. When in she won't do a thing.
she actually has backed off on the rhetoric talk now that congress had their worthless investigation that will lead no where.
Icahn has made so much money on his coming into a biotech when down to insane levels and buying up a big stake and getting board seats, forcing management to get their fiduciary acts together and eventually selling it out for a huge premium. His presence here would have a profound effect to getting this company valued in the 70 to 100 range
581 market cap and 280 million of it in cash for a multi billion dollar drug is a great return for any one of these companies here. Company set itself up for a bid by letting it get so cheap.